Recent Blog Postings
Sustainability is becoming a standard feature of modern architecture and design. You might already be familiar with home and office design solutions that make efficient use of resources. Sustainable laboratory design, however, has the potential to make a much larger impact than other building applications. In fact, conventional laboratories may use over 5 times as much energy per square foot as an office building and a similarly disproportionate amount of water.
Polycystic Kidney Disease (PKD) is the most frequently inherited kidney disorder and affects nearly 600,000 Americans and as many as 12 million people worldwide. Currently, there are no FDA approved treatments for PKD.
Researchers at the University of Kansas have created a novel compound and method for treating PKD that leads to the inhibition of cyst growth.
This past week I was thrilled to present during the Pipeline Innovator of the Year competition as a student spotlight. Pipeline Entrepreneurs is an “exclusive community of entrepreneurs building high-growth companies in the midwest.” I received this opportunity after winning the University of Kansas Start-Up Showcase last fall hosted by the KU Innovation and Collaboration.
With the increasing demand for low carbon energy solutions, improved solar power utilization has become necessary. Using earth abundant iron pyrite (FeS2) researchers at the University of Kansas have created an all-in-one solution that overcomes the long term challenges of solar power efficiency and the need for separate devices for photoelectron conversion and storage.
For patients that have experienced little or no results from products currently available to treat hair loss (alopecia), there could soon be a new product available. Researchers at the University of Kansas have created a new formula they are calling Murikal.
As the popularity of Unmanned Aircraft systems (UAS), also known as UAVs or drones, increases, so does the concern for how they are being utilized and piloted safely.
Over 5 million Americans have Alzheimer's disease, a neurodegenerative disorder resulting in loss of memory and other important mental functions. By 2050, the number is expected to climb to over 16 million.